182 related articles for article (PubMed ID: 7548271)
1. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
[TBL] [Abstract][Full Text] [Related]
2. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
6. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.
Zabner J; Petersen DM; Puga AP; Graham SM; Couture LA; Keyes LD; Lukason MJ; St George JA; Gregory RJ; Smith AE
Nat Genet; 1994 Jan; 6(1):75-83. PubMed ID: 7511023
[TBL] [Abstract][Full Text] [Related]
8. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
[TBL] [Abstract][Full Text] [Related]
9. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo.
Nicolis E; Tamanini A; Melotti P; Rolfini R; Berton G; Cassatella MA; Bout A; Pavirani A; Cabrini G
Gene Ther; 1998 Jan; 5(1):131-6. PubMed ID: 9536274
[TBL] [Abstract][Full Text] [Related]
11. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.
Goldman MJ; Litzky LA; Engelhardt JF; Wilson JM
Hum Gene Ther; 1995 Jul; 6(7):839-51. PubMed ID: 7578403
[TBL] [Abstract][Full Text] [Related]
12. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates.
Sené C; Bout A; Imler JL; Schultz H; Willemot JM; Hennebel V; Zurcher C; Valerio D; Lamy D; Pavirani A
Hum Gene Ther; 1995 Dec; 6(12):1587-93. PubMed ID: 8664383
[TBL] [Abstract][Full Text] [Related]
13. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.
Rich DP; Couture LA; Cardoza LM; Guiggio VM; Armentano D; Espino PC; Hehir K; Welsh MJ; Smith AE; Gregory RJ
Hum Gene Ther; 1993 Aug; 4(4):461-76. PubMed ID: 7691187
[TBL] [Abstract][Full Text] [Related]
14. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
Rosenfeld MA; Yoshimura K; Trapnell BC; Yoneyama K; Rosenthal ER; Dalemans W; Fukayama M; Bargon J; Stier LE; Stratford-Perricaudet L
Cell; 1992 Jan; 68(1):143-55. PubMed ID: 1370653
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for the respiratory manifestations of cystic fibrosis.
Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
[TBL] [Abstract][Full Text] [Related]
17. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
18. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
[TBL] [Abstract][Full Text] [Related]
19. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
Amalfitano A; Begy CR; Chamberlain JS
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
Eissa NT; Chu CS; Danel C; Crystal RG
Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
